The role of inflammation in cardiovascular disease.

The article in this issue by Gussekloo et al,1 “C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons,” demonstrates 2 important points. First, for maximum predictive value, a variable such as C-reactive protein (CRP) should preferably be a risk factor for a specific outcome rather than for a broad range of unrelated outcomes such as stroke, coronary heart disease, cancer, and total mortality. There are some risk factors such as cigarette smoking and radiation exposure that are associated with many different outcomes, and future work may show that CRP falls into this important category. However, in general, the specificity of an association is an important component, often reflecting a causal relationship. These investigators determined that elevated CRP is …

[1]  P. Sakkinen,et al.  Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[2]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[4]  R. Westendorp,et al.  C-Reactive Protein Is a Strong but Nonspecific Risk Factor of Fatal Stroke in Elderly Persons , 2000 .

[5]  R. Westendorp,et al.  C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[6]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R. Tracy,et al.  Inflammation markers and coronary heart disease. , 1999, Current opinion in lipidology.

[8]  I. Kushner,et al.  C-reactive protein and the acute-phase response. , 1990, Hospital practice.

[9]  L. Kuller,et al.  Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.

[10]  Harry,et al.  C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.

[11]  J. Yudkin Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? , 1999, Diabetes Care.